Professional Documents
Culture Documents
DRUG ERUPTION
Preceptor :
dr. Ulynar
Marpaung, Sp.A
IDENTITY
Patient
Name
: S.S.
Birth date
: February 2 th 2003
Age
: 13 years old
Gender
: Female
Adress
: Komplek Polri Munjul
Nationality
: Indonesia
Religion
: Moslem
Date of admission : January 25th 2016
Date of examination : January 28th 2016
PARENTS
IDENTITY
Name
Age
Job
Nationality
Religion
Education
Address
Father
Mother
Mr. H
Mrs. N
44 years old
38 years old
Cleaning Service Housewife
Indonesia
Indonesia
Moslem
Moslem
High school
High school
(graduate)
(graduate)
Komplek Polri Munjul RT
009/RW 003
ANAMNESIS
The anamnesis was taken on January 25th 2016, by
autoanamnesis and alloanamnesis (from patient and
patients mother).
Chief complain
rash, itchy in her skin since 4 days before admission to the
hospital.
Additional complain
Fever, dizzy and shiver
Intermittent
fever and
comsumption
Cefixime
Patients
Patients skin skin was
was rash
rash itchy
itchy in her
in her
leg
extremitas,
stomach
and back
+
+
+
-
Bacillary dysentry
Amoeba dysentry
Diarrhea
Thyphoid
Worms
Surgery
Brain concussion
Fracture
Drug reaction
+
-
Allergic History
BIRTH HISTORY
Mothers pregnancy history
The mother routinely checked her pregnancy to the hospital. She
denied any problem noted during pregnancy.
Childs birth history
Labor
: Cipto Mangun Kusumo Hospital
Birth attendants : Doctor
Mode of delivery : Pervaginam
Gestation : 38 week
Infant state : Healthy
Birth weight : 3000 grams
Body length : 40 cm
DEVELOPMENT
HISTORY
First dentition
: 6 months
Psycomotor development
Head up
: 1 month old
Smile
: 1 month
Laughing
: 1-2 month old
Slant
: 2,5 month old
Speech initiation
: 5 month old
Prone podition : 5 month old
Immunization
History of History
Eating
Immunization Frequen
cy
Time
4 times
0,2,4,6
months old
BCG
DPT
3 times
2,4,6
months old
Hib
3 times
2,4,6
months old
Measles
1 time
9 months
old
Family History
History of Disease
in
Other
Family
There are no significant
Member
illness or chronic illness
in the family declared.
There is no one living
Patients mother have meat
around their home known
Allergy
for having same
condition as the patient.
PHYSICAL EXAMINATION
( JANUARY 10th 2016)
General status
General condition : Mild ill
Awareness
: Compos mentis
Pulse
: 90 x/min, regular, full,
strong
Breathing rate
: 22 x/min
Temperature
: 36 0C
ANTHROPOMETRY
STATUS
Weight : 39 kg
Height : 151 cm
Nutritional status based NCHS
2000
(National Center for Health
Statistic) year 2000
WFA (Weight for Age)
39/45 x 100% = 86 %
HFA (Height for Age)
151/157 x100% = 96 %
Conclusion:
The
nutritional status.
patient
has
good
: Moist
Mucous
Tongue
: Moist
Tonsils
Pharynx
: T1/T1, no hyperemia
: Not dirty
: No hyperemia
Neck
Lymph node enlargement (-), scrofuloderma (-).
Neurological Examination
Meningeal sign
Nuchal rigidity
Kernig sign
Lasegue sign
Brudzinski 1
Brudinski 2
MOTORIC EXAMINATION
Power
Hand
5 5 5 5/ 5 5 5 5
Feet
5 5 5 5/ 5 5 5 5
Tonus
Hand
Normotonus / Normotonus
Feet
Normotonus / Normotonus
Trophy
Hand
Normotrophy / Normotrophy
Feet
Normotrophy / Normotrophy
Physiologic Reflex
Upper extrimities
Biceps
+/+
Triceps
+/+
Lower extrimities
Patella
+/+
Achilles
+/+
-/-
Trommer
-/-
Clonus
Lower extrimities
Babinsky
-/-
Chaddock
-/-
Oppenheim
-/-
Gordon
-/-
Schaeffer
-/-
Patella
-/-
Achilles
-/-
AUTONOM EXAMINATION
Defecation
Urination
Sweating
Normal
LABORATORY INVESTIGATION
HEMATOLOGY JANUARY 25 TH 2016
Hematology
Results
Normal Value
Hemoglobin
14,9
13-16 g/dL
Leukocytes
2.700
5,000
Hematocrytes
41
10,000/L
40 48 %
Trombocytes
135.000
150,000
400,000/L
WORKING DIAGNOSIS
Suspect Drug Eruption, Urtikaria
MANAGEMENT
IVFD RL 24 dpm
Inj. Ceftriaxone 2 x 1 g i.v.
Inj. Rantin 2 x 1 amp i.v.
Inj. Dexamethasone 2 x amp IV
PCT syrp 3 x 1 cth P.O
PROGNOSIS
Quo ad vitam
: dubia ad bonam
Quo ad functionam : dubia ad bonam
Quo ad sanactionam : dubia ad bonam
FOLLOW UP
JANUARY 25 2016
TH
JANUARY 28 2016
TH
January 25 th 2016
S : Fever (-)
Dizzy (+)
Rash (+)
Cough (-)
O : General condition : Compos mentis
Blood Pressure
: 110/90 mmHg
Heart Rate : 90x/m
Respiratory Rate : 20x/m
Temperature
: 36 C
Eyes
: Normal
Cardio
: Normal
Pulmonary
: Normal
Extremities
Results
Normal Value
Hemoglobin
14,9
13-16 g/dL
Leukocytes
2.700
5,000
Hematocrytes
41
10,000/L
40 48 %
Trombocytes
135.000
150,000
400,000/L
January 26 th 2016
S : Fever (-)
Dizzy (+)
Rash (++)
Cough (-)
Hematology
Results
Normal Value
Hemoglobin
15,6
13-16 g/dL
Leukocytes
4.100
5,000
44
10,000/L
40 48 %
56.000
150,000
Hematocrytes
Trombocytes
O : General condition : Compos mentis
Blood Pressure
: 100/70 mmHg
Heart Rate : 88x/m
400,000/L
: Normal
Cardio
: Normal
Pulmonary
: Normal
Extremities
January 27 th 2016
S : Fever (-)
Dizzy (-)
Rash (-)
Cough (-)
O : General condition : Compos mentis
Blood Pressure
: 110/80 mmHg
Heart Rate : 86x/m
: 36 C
Eyes
: Normal
Cardio
: Normal
Pulmonary
: Normal
Extremities
Hematology
Results
Normal Value
Hemoglobin
14,7
13-16 g/dL
Leukocytes
7.700
5,000
Hematocrytes
42
10,000/L
40 48 %
Trombocytes
81.000
150,000
400,000/L
January 28 th 2016
S : Fever (-)
Dizzy (-)
Rash (-)
O : General condition : Compos mentis
Blood Pressure
: 110/80 mmHg
Heart Rate : 89x/m
Respiratory Rate : 22x/m
Temperature
: 36 C
Eyes
: Normal
Cardio
: Normal
Hematology
Results
Normal Value
Pulmonary
: Normal
Hemoglobin
14,5
13-16 g/dL
Extremities
Leukocytes
7.700
5,000
Hematocrytes
41
10,000/L
40 48 %
Trombocytes
119.000
150,000
400,000/L
DRUG ERUPTION
Literature Review
Drug Eruptions
EPIDEMIOLOG
Y
Classification
By appearance
The most common type of eruption is a morbilliform
resembling measles or erythematous rash
By mechanism
The underlying mechanism can be immunological in drug or
non-immunological
By drug
The culprit can be both a prescription drug or an overcounter medication.(antibiotic, analgesic,herbal supplement)
Over Dose
Side Effects
Cumulative Toxicity
Delayed Toxicity
Facultative Effects
Drug Interaction
Metabolic Changes
Teratogenicity of Fetus
Activation of Effector Pathways
Exacerbation of Diseases
Chromosomal Damage by Drug
Intolerance and Idiosyncrasy
Jarisch herxheimer reaction
Infectious mono - , ampicillin reaction
PATHOPHYSIOLOGY
PATHOPHYSIOLOG
Y
Allergic Reaction
(Immunologic)
less
than 6-10%
Non allergic Reaction (Non
Immunologic) More than . 90%
Drug-induced exanthems
Urticaria
Angioedema/anaphylaxis
Hypersensitivity vasculitis
Exfoliative dermatitis/Erythroderma
Fixed drug eruption
DRUG-INDUCED EXANTHEMS
Account for close to 75% of all drug eruptions.
Morbilliform, maculopapular eruptions.
Most commonly implicated medications are the most
commonly prescribed medications (antibiotics, sulfa).
Usually begin in generalize areas .
Often associated with pruritis, low-grade fever,
eosinophilia.
Onset within 2 weeks of starting a new drug, or
within days of re-exposure.
Delayed (type IV) hypersensitivity is most likely
etiology.
More common in patients with altered immunity,
such as those with HIV or mononucleosis (ampicillin
rash).
Drug-induced
Exanthems
URTICARIA:
Time to onset: immediate, accelerated
(hours), or delayed (days).
Immunological (Type I hypersensitivity
reactions) :antibiotics (especially PCN,
cephalosporins, and sulfonamides), local
anesthetics, radiocontrast media, blood
products, and gamma globulin.
Non-immune urticaria: Mast cell
degranulation by non-IgE mechanisms: opiate
analgesics, anesthetic, muscle relaxants, and
Vancomycin (Red Man Syndrome).
ANGIOEDEMA/ANAPHYLAXIS
May occur along with urticaria (50% of
cases)
Can be life-threatening if it causes laryngeal
edema or tongue swelling.
Can be non-mast cell mediated, as in the
case of ACE-inhibitors.
Angioedema/An
aphylaxis
HYPERSENSITIVITY VASCULITIS(DHS)
American College of Rheumatology proposed the following
five criteria. The presence of three or more had a sensitivity
of 71% and a specificity of 84% for the diagnosis
Age > 16
Use of possible offending drug in temporal relation to
symptoms
Palpable purpura
Maculopapular rash
Biopsy of a skin lesion showing neutrophils around an
arteriole or venule.
Most likely due to drugs that can act as haptens to
stimulate the immune response: PCN, cephalosporins,
sulfonamides, phenytoin, and allopurinol.
Additional findings: fever, urticaria, arthralgias, low
complement (CH50) levels, and elevated ESR .
Hypersensitivity
vasculitis
DIAGNOSE
1.Anamnesis
2.Physical examination
3.Biopsy e.g. by showing eosinophils in
morbilliform eruptions or numerous neutrophils
without vasculitis
4.CBC count with differential may show
leukopenia, thrombocytopenia, and eosinophilia
in patients with serious drug eruptions
TREATMENT stage
Treatment of a drug eruption depends on the
specific type of reaction
Therapy for exanthematous drug eruptions is
supportive in nature.
First-generation antihistamines are used
mild topical steroids (e.g. hydrocortisone(
moisturizing lotions, especially during the late
desquamative phase
TREATMENT stage
Topical steroids may provide
some relief
If signs and symptoms are
severe, a 2-week course of
systemic corticosteroids
(prednisone, starting at 40- 60
mg) will usually stop the
symptoms and prevent further
progression of the eruption
REFERENCES
Kliegman, R. and Nelson, W. (2007). Nelson textbook of pediatrics.
Philadelphia: Saunders.
Hall, J. and Guyton, A. (2006). Guyton & Hall physiology review.
Philadelphia: Elsevier Saunders.
Kumar, V., Abbas, A., Fausto, N. and Aster, J. (2014). Robbins and
Cotran Pathologic Basis of Disease, Professional Edition. London:
Elsevier Health Sciences.
Tortora, G. and Grabowski, S. (2009). Principles of anatomy and
physiology. New York: Wiley.
Martin, J., Kaul, A. and Schacht, R. (2012). A Manifestation of Immune
Reconstitution Inflammatory Syndrome. PEDIATRICS, 130(3), pp.e710e713.
Vinen, C. (2013).. Postgraduate Medical Journal, 79(930), pp.206-213.
Images provided by the Dermatology Image Atlas - Johns
Hopkins University. http://dermatlas.med.jhmi.edu/derm/
THANKYOU